Paolo Antonio Ascierto MD

Dr. Paolo A. Ascierto is the Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples, Italy. He received his medical degree from the University of Naples, where he earned board certification in oncology. Before his present position at the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy of the National Tumor Institute, he previously served there as a postdoctoral fellow and then vice-director of the Department of Clinical Immunology.

Dr. Ascierto’s primary research interests have included research in the genetics and proteomics of melanoma, assessment of new molecular markers for tumor progression in patients with malignant melanoma, targeted therapies for melanoma, biochemical and immunological monitoring, and immunotherapy and vaccination treatments. He has served as principal investigator in numerous clinical trials and has been well-published in peer-reviewed journals on topics related to his research interests.

Dr. Ascierto serves on editorial boards for the Journal of Translational Medicine, the Journal of Immunotherapy of Cancer, Combination Products in Therapy, the Journal of Skin Cancer, and Dataset Papers in Immunology. He is the Editor-in-Chief of the Combination Strategies section for the Journal of Translational Medicine. He has also been an invited speaker at more than 350 national and international conferences and meetings and maintains active memberships in several medical societies in Italy and abroad.